Classification, epidemiology, and natural history of fibromyalgia

被引：173

作者：

White K.P. ^{[1
]}

Harth M. ^{[1
]}

机构：

[1] Department of Medicine, University of Western Ontario, K289, 268 Grosvenor Street, P.O. Box 5777, London, N6A 4V2, ON

来源：

Current Pain and Headache Reports | 2001年 / 5卷 / 4期

关键词：

Chronic Widespread Pain; Fibromyalgia; Fibromyalgia Syndrome; Rheumatol; Tender Point;

D O I：

10.1007/s11916-001-0021-2

中图分类号：

学科分类号：

摘要：

Fibromyalgia (FM), also known as fibromyalgia syndrome (FMS) and fibrositis, is a common form of nonarticular rheumatism that is associated with chronic generalized musculoskeletal pain, fatigue, and a long list of other complaints. Some have criticized the classification of FM as a distinct medical entity, but existing data suggest that individuals meeting the case definition for FM are clinically somewhat distinct from those with chronic widespread pain who do not meet the full the FM definition. Clinic studies have found FM to be common in countries worldwide; these include studies in specialty and general clinics. The same is true of general population studies, which show the prevalence of FM to be between 0.5% and 5%. Knowledge about risk factors for FM is limited. Females are at greater risk, and risk appears to increase through middle age, then decline. Although some authors claim that an epidemic of FM has been fueled by an over-generous Western compensation system, there are no data that demonstrate an increasing incidence or prevalence of FM; moreover, existing data refute any association between FM prevalence and compensation. Claims that the FM label itself causes illness behavior and increased dependence on the medical system also are not supported by existing research. This article reviews the classification, epidemiology, and natural history of FM. © 2001, Current Science Inc.

引用

页码：320 / 329

页数：9

共 103 条

[1]

Lawrence R.C., Hochberg M.C., Kelsey J.L., Et al., Estimates of prevalence of selected arthritic and musculoskeletal diseases in the United States, J Rheumatol, 16, pp. 427-441, (1989)

[2]

Magni G., Marchetti M., Moreschi C., Et al., Chronic musculoskeletal pain and depressive symptoms in the National Health and Nutrition Examination. I. Epidemiologic follow-up study, Pain, 53, pp. 163-168, (1993)

[3]

Wolfe F., Ross K., Anderson J., Et al., The prevalence and characteristics of fibromyalgia in the general population, Arthritis Rheum, 38, pp. 19-28, (1995)

[4]

Felts W., Yelin E., The economic impact of the rheumatic diseases in the United States, J Rheumatol, 16, pp. 867-884, (1989)

[5]

Lee P., Helewa A., Smythe H., Et al., Epidemiology of musculoskeletal disorders (complaints) and related disability in Canada, J Rheumatol, 12, pp. 1169-1173, (1985)

[6]

White K.P., Speechley M., Harth M., Ostbye T., The London Fibromyalgia Epidemiology Study: the prevalence of fibromyalgia syndrome in London, Ontario, J Rheumatol, 26, pp. 1570-1576, (1999)

[7]

Reynolds D.L., Chambers L.W., Badley E.M., Et al., Physical disability among Canadians reporting musculoskeletal diseases, J Rheumatol, 19, pp. 1020-1030, (1992)

[8]

Andersson H.I., Ejlertsson G., Leden I., Rosenberg C., Chronic pain in a geographically defined general population: studies of differences in age, gender, social class, and pain localization, Clin J Pain, 9, pp. 174-182, (1993)

[9]

Hagen J.B., Kvien T.K., Bjorndal A., Musculoskeletal pain and quality of life in patients with non-inflammatory joint pain compared to rheumatoid arthritis: a population study, J Rheumatol, 24, pp. 1703-1709, (1997)

[10]

Croft P., Rigby A.S., Boswell R., Et al., The prevalence of chronic widespread pain in the general population, J Rheumatol, 20, pp. 710-713, (1993)

← 1 2 3 4 5 6 7 8 9 10 →